Anti-GABAB Receptor 2 Antibody [N81/2 (Formerly sold as S81-2)]

(No reviews yet) Write a Review
SKU:
STMA00117
Antibody Type:
Monoclonal
Applications:
WB
Applications:
IHC
Applications:
ICC/IF
Reactivity:
Human
Reactivity:
Mouse
Reactivity:
Rat
Host Species:
Mouse
Isotype:
IgG1
  • Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-GABA-B Receptor 2 Monoclonal Antibody, Clone N81/2 (STMA00117). Tissue: Neuroblastoma cells (SH-SY5Y). Species: Human. Fixation: 4% PFA for 15 min. Primary Antibody: Mouse Anti-GABA-B Receptor 2 Monoclonal Antibody (STMA00117) at 1:100 for overnight at 4°C with slow rocking. Secondary Antibody: AlexaFluor 488 at 1:1000 for 1 hour at RT.
  • Western Blot analysis of Rat Brain Membrane showing detection of ~105 kDa GABA B Receptor 2 protein using Mouse Anti-GABA B Receptor 2 Monoclonal Antibody, Clone N81/2 (STMA00117). Lane 1: MW Ladder. Lane 2: Rat Brain Membrane (10 µg). Load: 10 µg. Block: 5% milk. Primary Antibody: Mouse Anti-GABA B Receptor 2 Monoclonal Antibody (STMA00117) at 1:1000 for 1 hour at RT. Secondary Antibody: Goat Anti-Mouse IgG: HRP at 1:200 for 1 hour at RT.
Frequently bought together:

Description

GABAB Receptor 2 Antibody [N81/2 (Formerly sold as S81-2)]

GABAB Receptor 2 Antibody [N81/2 (Formerly sold as S81-2)] is a mouse monoclonal antibody directed against GABAB Receptor 2, offered by Assay Genie for research applications. Reported applications include WB, IHC and ICC/IF. Reported reactivity: Human, Mouse and Rat. Supplied as IgG1, purified by Protein G.

GABA (γ-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system, acting through three receptor types: GABA-A, GABA-B, and GABA-C. While GABA-A and GABA-C receptors are ionotropic and mediate rapid synaptic inhibition, GABA-B receptors are metabotropic, G protein-coupled receptors that regulate slower, prolonged inhibitory signaling. Functional GABA-B receptors are obligate heterodimers composed of GABA-B Receptor 1 (GABBR1), which binds GABA, and GABA-B Receptor 2 (GABBR2), which is essential for G protein coupling and intracellular signaling. GABBR2 plays a pivotal role in activating downstream pathways that inhibit adenylate cyclase, suppress voltage-gated calcium channels, and activate inwardly rectifying potassium channels. These mechanisms contribute to both presynaptic inhibition—by reducing neurotransmitter release—and postsynaptic inhibition—by hyperpolarizing neurons. Beyond its role in synaptic inhibition, GABBR2 is involved in regulating hippocampal long-term potentiation, sleep architecture, and motor control. Dysregulation of GABBR2 has been increasingly implicated in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Altered GABBR2 expression or function may disrupt inhibitory tone, contribute to excitotoxicity, and impair synaptic plasticity—key features of neurodegeneration. As a result, GABBR2 is emerging as a promising therapeutic target and biomarker in neuroscience, offering new opportunities for modulating GABAergic signaling to preserve cognitive and neural function in aging and disease. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose